American Heart Journal
Volume 157, Issue 1 , Pages 37-45 , January 2009

Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle

  • Daphne T. Hsu, MD

      Affiliations

    • Columbia University, New York, NY
    • Corresponding Author InformationReprint requests: Daphne T. Hsu, MD, Children's Hospital at Montefiore, R3, 3415 Bainbridge Ave., Bronx, NY 10467.
    • ,
  • Seema Mital, MD

      Affiliations

    • Columbia University, New York, NY
    • ,
  • Chitra Ravishankar, MD

      Affiliations

    • Children's Hospital of Philadelphia, Philadelphia, PA
    • ,
  • Renee Margossian, MD

      Affiliations

    • Children's Hospital Boston, Boston, MA
    • ,
  • Jennifer S. Li, MD

      Affiliations

    • Duke University, Durham, NC
    • ,
  • Lynn A. Sleeper, ScD

      Affiliations

    • New England Research Institutes, Watertown, MA
    • ,
  • Richard V. Williams, MD

      Affiliations

    • Primary Children's Medical Center, Salt Lake City, UT
    • ,
  • Jami C. Levine, MD

      Affiliations

    • Children's Hospital Boston, Boston, MA
    • ,
  • Brian W. McCrindle, MD

      Affiliations

    • Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Andrew M. Atz, MD

      Affiliations

    • Medical University of South Carolina, Charleston, SC
    • ,
  • Darlene Servedio, RN

      Affiliations

    • Columbia University, New York, NY
    • ,
  • Lynn Mahony, MD

      Affiliations

    • University of Texas at Southwestern Medical Center, Dallas, TX
    • ,
  • for the Pediatric Heart Network Investigators

Received 18 July 2008 ,Accepted 12 August 2008.

References 

  1. Cheung YF, Penny DJ, Redington AN. Serial Assessment of Left Ventricular Diastolic Function after Fontan Procedure. Heart. 2000;83:420–424
  2. Gentles TA, Mayer JE, Gauvreau K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114:376–391
  3. Seliem M, Muster AJ, Paul MH, et al. Relation between preoperative left ventricular muscle mass and outcome of the Fontan procedure in patients with tricuspid atresia. J Am Coll Cardiol. 1989;14:750–755
  4. Mori Y, Nakazawa M, Tomimatsu H, et al. Long term effect of angiotensin-converting enzyme inhibitor in volume overload heart during growth: a controlled pilot study. J Am Coll Cardiol. 2000;36:270–275
  5. Calabro R, Piscane C, Pacileo G, et al. Hemodynamic effects of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am J Cardiol. 1999;138:955–961
  6. Shaw NJ, Wilson N, Dickinson DF. Captopril in heart failure secondary to a left to right shunt. Arch Dis Child. 1988;63:360–363
  7. Scammell AM, Arnold R, Wilkinson JL. Captopril in treatment of infant heart failure: a preliminary report. Int J Cardiol. 1987;16:295–301
  8. Frenneaux M, Stewart RAH, Newman CMH, et al. Enalapril for severe heart failure in infancy. Arch Dis Child. 1989;64:219–223
  9. Grenier MA, Fioravanti J, Truesdell SC, et al. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review. Prog Pediatr Cardiol. 2000;12:91–111
  10. Montigny M, Davignon A, Fouron JC, et al. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt. Am J Cardiol. 1989;63:631–633
  11. Seguchi M, Nakazawa M, Momma K. Effect of enalapril on infants and children with congestive heart failure. Cardiol Young. 1992;14–19
  12. Leitch CA. Growth, nutrition and energy expenditure in pediatric heart failure. Prog Pediatr Cardiol. 2000;11:195–202
  13. Cameron JW, Rosenthal A, Olson AD. Malnutrition in hospitalized children with congenital heart disease. Arch Pediatr Adolesc Med. 1995;149:1098–1102
  14. Cohen MI, Bush DM, Perry RJ, et al. Somatic growth failure after the Fontan operation. Cardiol Young. 2002;10:447–457
  15. Day RW, Denton DM, Jackson WD. Growth of children with a functionally single ventricle following palliation at moderately increased altitude. Cardiol Young. 2000;10:193–200
  16. Vogt KN, Manlhiot C, Van Arsdell G, et al. Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol. 2007;50:1876–1883
  17. Mahony L, Sleeper LA, Anderson PA, et al. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol. 2006;27:191–198
  18. Ross RD, Daniels SR, Schwartz DC, et al. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol. 1987;59:911–914
  19. Wu J, Chang H, Huang T, et al. Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease. Am J Cardiol. 1996;77:170–174
  20. Shimizu H, Aono K, Masuta K, et al. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta. 1999;285:169–172
  21. Bayley N. Bayley Scales of Infant Development. 2nd ed.. San Antonio (TX): Psychol. Corp.; 1993;
  22. Fenson L, Dale P, Reznick S, et al. MacArthur Communicative Development Inventories: User's Guide and Technical Manual. San Diego (CA): Singular Publishing Group; 1993;
  23. Bernstein D, Starnes VA, Baum D. Pediatric heart transplantation. Adv Pediatr. 1990;37:413–439
  24. Tabbutt S, Nord AS, Jarvik GP, et al. Neurodevelopmental outcomes after staged palliation for hypoplastic left heart syndrome. Pediatrics. 2008;121:476–483
  25. Missmer S, Spiegelman D, Gorbach S, et al. Predictors of change in the functional status of children with human immunodeficiency virus infection. Pediatrics. 2000;106:http://www.pediatrics.org/cgi/content/full/106/2/e24Last accessed November 21, 2008.
  26. Sleeper LA, Anderson P, Hsu DT, et al. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006;152:427–433
  27. Ortlepp JR, Vosberg HP, Reith S, et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart. 2002;87:270–275
  28. Kurland L, Melhus H, Karlsson J, et al. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens. 2002;20:657–663
  29. Matsumoto T, Wada A, Ohnishi M, et al. Chymase gene Expresses in only the Severe Stages of Heart Failure, while ACE Gene Expresses throughout the Cardiac Remodeling Process. Circulation. 2000;2191;[Abstract]
  30. Lan K, DeMets D. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659–663

 Trial Registration #: NCT00113087.

 Funded by the National Heart, Lung, and Blood Institute (Bethesda, MD), National Institutes of Health (Bethesda, MD)/Department of Health and Human Services (Washington, DC).

 Supported by U01 grants from the National Heart, Lung, and Blood Institute (HL068269, HL068270, HL068279, HL068281, HL068285, HL068292, HL068290, HL068288, HL085057).

 Dr. J. Michael DiMaio served as guest editor for this manuscript.

PII: S0002-8703(08)00804-1

doi: 10.1016/j.ahj.2008.08.030

American Heart Journal
Volume 157, Issue 1 , Pages 37-45 , January 2009

Article Tools

* Image Usage & Resolution